Glaucoma and macular degeneration treatment near?
Nanotechnology is being applied to almost everything and it’s really growing fast. Under it’s most important subfield – nanomedicine, many researches are being done every day. Professor Mallik from NDSU and his crew have done a nanoparticle research which is concentrated on ophthalmology.
The promise of this research is that eye diseases such as glaucoma and macular degeneration could become history. The researchers from NDSU have worked with a nanoparticle called nanoceria and used it as a drug delivery device. Normally, the brain-blood barrier prevents medicines from breaking through, but since nanodevices are very small, they can pass it. Professor Mallik said that nanoceria appears to be nontoxic, but the drugs they attach to it might be.
National Institute of Health recently handed Mallik a $1.47 million grant for research.
